Investor call for ethical activity during COVID-19 fight

A group of mostly Dutch investors is calling on the biopharma sector to proactively collaborate and act responsibly in the fight against COVID-19. Companies that don’t comply risk divestment.

While the group is actively monitoring an undisclosed set of companies, they have not set clear metrics of bad behavior or thresholds that would trigger divestiture. And the vast majority of biopharma companies involved in developing solutions for the pandemic are already meeting most, if not all, of the principles the investors laid out in a letter to companies published on April 16...